EIB to fund Spain’s Almirall for skin health research

EPA/MARIUS BECKER

A model demonstrates the 'BlueControl' medical device from Philips at a medical fair in Duesseldorf, Germany, 11 November 2014. The blue light reduces the symptoms of psoriasis. More than 4,800 exhibitors will display their producrs at the world's largest medical technology fair.

EIB to fund Spain’s Almirall for skin health research


Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+

The European Investment Bank signed on 25 June an €120 million loan agreement with Almirall, S.A. to support its research and development activities related to skin health care therapeutic products.
The implementation of the project will seek new pharmaceutical responses to pathologies such as psoriasis, atopic dermatitis and actinic keratosis, a type of precancerous cutaneous lesion.

Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+